About GnuBIO

GnuBIO is a developer of scalable DNA sequencing technology for both the Diagnostic and Applied markets. The GnuBIO technology is an emulsion-based microfluidic technology, which provides a scalable desktop sequencing system that allows interrogation of single genes, gene panels, and whole genomes. Using a proprietary DNA sequencing system, the GnuBIO’s platform encompasses all the steps required for DNA sequencing into a single platform including target selection and enrichment, DNA amplifica

Company Highlights
Year Founded

2009

icon-altStatus

Acquired

icon-altEmployees

1

Location (HQ)

USA

Since Last Funding

11 years 11 months

Monthly Website Visitors

2.7K

icon-altTotal Investment Amt

$23M

Last Funding Round

Series B

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Health Care

Biotechnology

Medical Device

Biotechnology Research

Genetics